$Genelux (GNLX.US)$ Reuters· 1 min ago
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy With Olvi-Vec in Non-Small Cell Lung Cancer

$Genelux (GNLX.US)$
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer

$Genelux (GNLX.US)$ 5 analysts have this as a buy. Also close to a gap up but could take a few days to reach that gap but will be worth it.
$Healthy Choice Wellness (HCWC.US)$ 2nd day rally.  Im in at 5.15.
$Kairos Pharma (KAPA.US)$ Also. Im in at 2.25.
$Knightscope (KSCP.US)$  Extremely high short interest after RS. Buying in at open with a goal of 7.75.
Plan on being in the green and up 40% at the end of the day.

$Genelux (GNLX.US)$
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
Genelux (NASDAQ: GNLX) reported its Q2 2024 financial results and provided business updates. The company completed a $30 million public offering, providing runway through three trial readouts. Genelux anticipates interim results from the Phase 2 trial in recurrent non-small cell lung cancer by mid-2025 and interim data from the Phase 1b trial in recurrent small cell...

Pushing back into the 90 day POC. Above 2.70 could make a run at the open GAP above.
Larger Image: tradingview.com...
$Genelux (GNLX.US)$

$Genelux (GNLX.US)$ orbit

$Genelux (GNLX.US)$ missed it
dropped from 35-20 in 7 days
missed my entry

$ICZOOM Group (IZM.US)$ chinese ipo uptrending, same underwriter as $Genelux (GNLX.US)$

$Genelux (GNLX.US)$ markets best kept secret right here